These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 31599882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR, Iñiguez IR, Gilmour S, Yap J.
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [Abstract] [Full Text] [Related]

  • 3. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A, Brandt A, Conzelmann IB, Özel Y, Bergheim I.
    Nutrients; 2018 Sep 19; 10(9):. PubMed ID: 30235828
    [Abstract] [Full Text] [Related]

  • 4. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
    Thiagarajan S, Shrinuvasan S, Arun Babu T.
    Indian J Gastroenterol; 2022 Feb 19; 41(1):63-68. PubMed ID: 35064452
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dietary determinants of hepatic fat content and insulin resistance in overweight/obese children: a cross-sectional analysis of the Prevention of Diabetes in Kids (PREDIKID) study.
    Arenaza L, Medrano M, Oses M, Huybrechts I, Díez I, Henriksson H, Labayen I.
    Br J Nutr; 2019 May 19; 121(10):1158-1165. PubMed ID: 30832745
    [Abstract] [Full Text] [Related]

  • 8. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
    Villanueva-Ortega E, Garcés-Hernández MJ, Herrera-Rosas A, López-Alvarenga JC, Laresgoiti-Servitje E, Escobedo G, Queipo G, Cuevas-Covarrubias S, Garibay-Nieto GN.
    Ann Hepatol; 2019 May 19; 18(5):693-700. PubMed ID: 31151875
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC, Hung HF, Lu CW, Chang HH, Lee LT, Huang KC.
    Sci Rep; 2016 Jun 01; 6():27034. PubMed ID: 27246655
    [Abstract] [Full Text] [Related]

  • 12. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
    Furthner D, Anderwald CH, Bergsten P, Forslund A, Kullberg J, Ahlström H, Manell H, Ciba I, Mangge H, Maruszczak K, Koren P, Schütz S, Brunner SM, Schneider AM, Weghuber D, Mörwald K.
    Front Endocrinol (Lausanne); 2022 Jun 01; 13():830012. PubMed ID: 35185803
    [Abstract] [Full Text] [Related]

  • 13. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
    Rajindrajith S, Pathmeswaran A, Jayasinghe C, Kottahachchi D, Kasturiratne A, de Silva ST, Niriella MA, Dassanayake AS, de Silva AP, de Silva HJ.
    BMC Gastroenterol; 2017 Nov 29; 17(1):135. PubMed ID: 29187144
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis.
    Morandi A, Di Sessa A, Zusi C, Umano GR, El Mazloum D, Fornari E, Miraglia Del Giudice E, Targher G, Maffeis C.
    J Clin Endocrinol Metab; 2020 Nov 01; 105(11):. PubMed ID: 32841326
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A, Pereira SE, Saboya CJ, Ramalho A.
    Biomed Res Int; 2015 Nov 01; 2015():839253. PubMed ID: 26120587
    [Abstract] [Full Text] [Related]

  • 16. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z, Malecka-Tendera E, Matusik P.
    Can J Gastroenterol Hepatol; 2018 Nov 01; 2018():9465784. PubMed ID: 29854716
    [Abstract] [Full Text] [Related]

  • 17. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
    Hernández MJG, Klünder M, Nieto NG, Alvarenga JCL, Gil JV, Huerta SF, Siccha RQ, Hernandez J.
    Endocr Pract; 2018 Mar 01; 24(3):294-301. PubMed ID: 29547047
    [Abstract] [Full Text] [Related]

  • 18. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y, Liu J, Wang G, Wang Y.
    Biol Sex Differ; 2023 Oct 09; 14(1):69. PubMed ID: 37814297
    [Abstract] [Full Text] [Related]

  • 19. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
    Runchey SS, Boyko EJ, Ioannou GN, Utzschneider KM.
    J Gastroenterol Hepatol; 2014 Mar 09; 29(3):589-96. PubMed ID: 24716226
    [Abstract] [Full Text] [Related]

  • 20. Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity.
    Di Sessa A, Grandone A, Marzuillo P, Umano GR, Cirillo G, Miraglia Del Giudice E.
    J Pediatr Endocrinol Metab; 2021 May 26; 34(5):607-612. PubMed ID: 33823088
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.